...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Article on NASH Liver Disease
5
Aug 17, 2019 07:35PM

iconoclast - Thanks for the article. I like the reference to being the only drug on the market for a few years. If DM is correct with the estimate of a 6 to 8 year lead, that makes our opportunity that much bigger.

After looking at the 5 year chart for ICPT I think we would all be happy if RVX made it to the same levels they did in the first half of 2015...close to US$ 315.00 per share.

tada

5
Aug 18, 2019 03:53AM
Share
New Message
Please login to post a reply